Robotic knee replacement market seen hitting $5.02 billion by 2030

The Business Research Company projects the robotic knee replacement market will grow from $2.77 billion in 2025 to $5.02 billion by 2030, driven by rising osteoarthritis cases, aging populations and faster adoption of robotic surgical tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Robotic knee replacement is moving from a niche surgical tool to a broader orthopedic growth market as hospitals seek more precise procedures, shorter stays and faster recovery. - The forecast points to sustained demand for robotic-assisted systems as total knee replacement volumes rise worldwide. - The market’s growth also signals more spending on AI planning, outpatient surgery centers and patient-specific implant technologies.

What happened: - The Business Research Company said the robotic knee replacement market will rise from $2.77 billion in 2025 to $3.12 billion in 2026. - The firm projects the market will reach $5.02 billion by 2030, implying a 12.7% compound annual growth rate. - The company released its 2026 market report on robotic knee replacement in London on July 7, 2026. - The report is titled, “The Business Research Company's Robotic Knee Replacement Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035.” - Download a free sample of the report. - View the full report.

The details: - Robotic knee replacement uses robotic-assisted systems, high-tech imaging and real-time data to help surgeons make bone cuts and place implants more precisely. - The approach is designed to improve implant alignment, surgical outcomes and recovery time while reducing complications. - The market’s 2025-to-2026 growth is tied to rising osteoarthritis cases, other joint disorders, an aging population, demand for advanced orthopedic surgery, expanding healthcare infrastructure and progress in robotic-assisted surgical technology. - The report points to AI-powered surgical planning, more investment in robotic orthopedic platforms, personalized implant solutions and outpatient robotic surgery centers as major growth drivers through 2030. - The same period is expected to bring more minimally invasive robotic procedures, patient-specific implant alignment, real-time intraoperative guidance and precision knee arthroplasty aimed at extending implant longevity. - The report says North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America and the Middle East and Africa. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The forecast reflects a broader shift in orthopedics toward automation and digital planning, not just incremental hardware upgrades. - The demand signal is strongest where knee replacement volumes are expected to climb for decades, especially in aging populations. - In November 2025, the National Institutes of Health reported that annual primary total knee arthroplasty procedures in the U.S. are expected to rise 110% by 2025, 182% by 2030 and 401% by 2040. - That volume outlook helps explain why robotic systems are gaining attention from device makers, hospitals and outpatient surgery providers.

What's next: - The market is likely to keep expanding as robotic platforms add AI planning, more precise implant alignment and faster recovery features. - Outpatient robotic surgery centers and personalized implant workflows are positioned to capture more procedure volume. - Regional competition is likely to intensify as Asia-Pacific outpaces other markets in growth.

The bottom line: - Robotic knee replacement is on track for steady double-digit growth through 2030, with demand rising alongside knee surgery volumes and hospitals pushing for more precise, lower-risk procedures.